{
  "solution_stats": {
    "total_solutions": 7,
    "details": [
      {
        "solution_id": 1,
        "steps_count": 5
      },
      {
        "solution_id": 2,
        "steps_count": 6
      },
      {
        "solution_id": 3,
        "steps_count": 3
      },
      {
        "solution_id": 4,
        "steps_count": 6
      },
      {
        "solution_id": 5,
        "steps_count": 8
      },
      {
        "solution_id": 6,
        "steps_count": 7
      },
      {
        "solution_id": 7,
        "steps_count": 5
      }
    ]
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule17",
              "prover9": "(A3 -> A5)",
              "prover9_expression": "(clinical_trial_completed(Drug_Candidate_A) -> side_effects_observed(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are completed, then side effects for Drug Candidate A are observed."
            },
            {
              "id": "Rule24",
              "prover9": "(A5 -> A4)",
              "prover9_expression": "(side_effects_observed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A))",
              "natural": "If side effects for Drug Candidate A are observed, then regulatory approval for Drug Candidate A is granted."
            }
          ],
          "conclusion": "(A3 -> A4)",
          "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is granted."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A3 -> A4)",
              "prover9_expression": "(clinical_trial_completed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is granted."
            },
            {
              "id": "Rule18",
              "prover9": "(A3 -> -A4)",
              "prover9_expression": "(clinical_trial_completed(Drug_Candidate_A) -> -regulatory_approval_granted(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is not granted."
            }
          ],
          "conclusion": "-A3",
          "natural": "Clinical trials for Drug Candidate A are not completed."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A2 -> A3)",
              "prover9_expression": "(clinical_trial_initiated(Drug_Candidate_A) -> clinical_trial_completed(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are initiated, then clinical trials for Drug Candidate A are completed."
            },
            {
              "id": "Derived",
              "prover9": "-A3",
              "prover9_expression": "-clinical_trial_completed(Drug_Candidate_A)",
              "natural": "Clinical trials for Drug Candidate A are not completed."
            }
          ],
          "conclusion": "-A2",
          "natural": "Clinical trials for Drug Candidate A are not initiated."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A2 | (-G -> A1))",
              "prover9_expression": "(clinical_trial_initiated(Drug_Candidate_A) | (-grant_awarded(Substance_Z) -> research_funded(Project_X)))",
              "natural": "Either clinical trials for Drug Candidate A are initiated or, if a grant for Substance Z is not awarded, then Project X receives research funding."
            },
            {
              "id": "Derived",
              "prover9": "-A2",
              "prover9_expression": "-clinical_trial_initiated(Drug_Candidate_A)",
              "natural": "Clinical trials for Drug Candidate A are not initiated."
            }
          ],
          "conclusion": "(-G -> A1)",
          "natural": "If a grant for Substance Z is not awarded, then Project X receives research funding."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-grant_awarded(Substance_Z) -> research_funded(Project_X))",
              "natural": "If a grant for Substance Z is not awarded, then Project X receives research funding."
            },
            {
              "id": "Fact2",
              "prover9": "-A1",
              "prover9_expression": "-research_funded(Project_X)",
              "natural": "Project X does not receive research funding."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule29",
              "prover9": "(-(A10 -> A11) -> A12)",
              "prover9_expression": "(-(manufacturing_process_approved(Drug_Candidate_A) -> mass_production_begun(Drug_Candidate_A)) -> manufacturing_process_revised(Drug_Candidate_A))",
              "natural": "If it is not the case that the manufacturing process for Drug Candidate A being approved leads to mass production of Drug Candidate A beginning, then the manufacturing process for Drug Candidate A is revised."
            },
            {
              "id": "Fact3",
              "prover9": "-A12",
              "prover9_expression": "-manufacturing_process_revised(Drug_Candidate_A)",
              "natural": "The manufacturing process for Drug Candidate A is not revised."
            }
          ],
          "conclusion": "(A10 -> A11)",
          "natural": "If the manufacturing process for Drug Candidate A is approved, then mass production of Drug Candidate A begins."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A10 -> A11)",
              "prover9_expression": "(manufacturing_process_approved(Drug_Candidate_A) -> mass_production_begun(Drug_Candidate_A))",
              "natural": "If the manufacturing process for Drug Candidate A is approved, then mass production of Drug Candidate A begins."
            },
            {
              "id": "Rule1",
              "prover9": "(A10 -> -A11)",
              "prover9_expression": "(manufacturing_process_approved(Drug_Candidate_A) -> -mass_production_begun(Drug_Candidate_A))",
              "natural": "If the manufacturing process for Drug Candidate A is approved, then mass production of Drug Candidate A does not begin."
            }
          ],
          "conclusion": "-A10",
          "natural": "The manufacturing process for Drug Candidate A is not approved."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule33",
              "prover9": "(-(A8 | A9) -> A10)",
              "prover9_expression": "(-(human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B)) -> manufacturing_process_approved(Drug_Candidate_A))",
              "natural": "If neither human trials for Drug Candidate B are initiated nor an alternative formulation for Drug Candidate B is developed, then the manufacturing process for Drug Candidate A is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A10",
              "prover9_expression": "-manufacturing_process_approved(Drug_Candidate_A)",
              "natural": "The manufacturing process for Drug Candidate A is not approved."
            }
          ],
          "conclusion": "(A8 | A9)",
          "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B))",
              "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
            },
            {
              "id": "Rule27",
              "prover9": "(A8 -> -A7)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If human trials for Drug Candidate B are initiated, then animal testing for Drug Candidate B is not completed."
            },
            {
              "id": "Rule28",
              "prover9": "(A9 -> -A7)",
              "prover9_expression": "(alternative_formulation_developed(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If an alternative formulation for Drug Candidate B is developed, then animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A7",
          "natural": "Animal testing for Drug Candidate B is not completed."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule25",
              "prover9": "(A6 -> A7)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) -> animal_testing_completed(Drug_Candidate_B))",
              "natural": "If the preclinical stage for Drug Candidate B is initiated, then animal testing for Drug Candidate B is completed."
            },
            {
              "id": "Derived",
              "prover9": "-A7",
              "prover9_expression": "-animal_testing_completed(Drug_Candidate_B)",
              "natural": "Animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A6",
          "natural": "The preclinical stage for Drug Candidate B is not initiated."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A6 | G)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) | grant_awarded(Substance_Z))",
              "natural": "Either the preclinical stage for Drug Candidate B is initiated or a grant for Substance Z is awarded."
            },
            {
              "id": "Derived",
              "prover9": "-A6",
              "prover9_expression": "-preclinical_stage_initiated(Drug_Candidate_B)",
              "natural": "The preclinical stage for Drug Candidate B is not initiated."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            {
              "id": "Rule30",
              "prover9": "(-(A13 -> G) -> A15)",
              "prover9_expression": "(-(compound_discovered(Substance_Z) -> grant_awarded(Substance_Z)) -> patent_approved(Substance_Z))",
              "natural": "If it is not the case that Substance Z being discovered leads to a grant for Substance Z being awarded, then the patent for Substance Z is approved."
            },
            {
              "id": "Rule2",
              "prover9": "(A15 -> A14)",
              "prover9_expression": "(patent_approved(Substance_Z) -> patent_filed(Substance_Z))",
              "natural": "If the patent for Substance Z is approved, then a patent for Substance Z is filed."
            }
          ],
          "conclusion": "(-(A13 -> G) -> A14)",
          "natural": "If it is not the case that Substance Z being discovered leads to a grant for Substance Z being awarded, then a patent for Substance Z is filed."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-(A13 -> G) -> A14)",
              "prover9_expression": "(-(compound_discovered(Substance_Z) -> grant_awarded(Substance_Z)) -> patent_filed(Substance_Z))",
              "natural": "If it is not the case that Substance Z being discovered leads to a grant for Substance Z being awarded, then a patent for Substance Z is filed."
            },
            {
              "id": "Rule31",
              "prover9": "(-(A13 -> G) -> -A14)",
              "prover9_expression": "(-(compound_discovered(Substance_Z) -> grant_awarded(Substance_Z)) -> -patent_filed(Substance_Z))",
              "natural": "If it is not the case that Substance Z being discovered leads to a grant for Substance Z being awarded, then a patent for Substance Z is not filed."
            }
          ],
          "conclusion": "(A13 -> G)",
          "natural": "If Substance Z is discovered, then a grant for Substance Z is awarded."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(compound_discovered(Substance_Z) -> grant_awarded(Substance_Z))",
              "natural": "If Substance Z is discovered, then a grant for Substance Z is awarded."
            },
            {
              "id": "Fact1",
              "prover9": "A13",
              "prover9_expression": "compound_discovered(Substance_Z)",
              "natural": "Substance Z is discovered."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule34",
              "prover9": "(-(-(A3 -> A4) -> -A16) -> A17)",
              "prover9_expression": "(-(-(clinical_trial_completed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A)) -> -clinical_trial_suspended(Drug_Candidate_A)) -> investigation_launched(Drug_Candidate_A))",
              "natural": "If it is not the case that the failure of clinical trials for Drug Candidate A being completed to lead to regulatory approval for Drug Candidate A being granted results in clinical trials for Drug Candidate A not being suspended, then an investigation into Drug Candidate A is launched."
            },
            {
              "id": "Fact4",
              "prover9": "-A17",
              "prover9_expression": "-investigation_launched(Drug_Candidate_A)",
              "natural": "An investigation into Drug Candidate A is not launched."
            }
          ],
          "conclusion": "(-(A3 -> A4) -> -A16)",
          "natural": "If it is not the case that clinical trials for Drug Candidate A being completed leads to regulatory approval for Drug Candidate A being granted, then clinical trials for Drug Candidate A are not suspended."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule32",
              "prover9": "(-(A3 -> A4) -> A16)",
              "prover9_expression": "(-(clinical_trial_completed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A)) -> clinical_trial_suspended(Drug_Candidate_A))",
              "natural": "If it is not the case that clinical trials for Drug Candidate A being completed leads to regulatory approval for Drug Candidate A being granted, then clinical trials for Drug Candidate A are suspended."
            },
            {
              "id": "Derived",
              "prover9": "(-(A3 -> A4) -> -A16)",
              "prover9_expression": "(-(clinical_trial_completed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A)) -> -clinical_trial_suspended(Drug_Candidate_A))",
              "natural": "If it is not the case that clinical trials for Drug Candidate A being completed leads to regulatory approval for Drug Candidate A being granted, then clinical trials for Drug Candidate A are not suspended."
            }
          ],
          "conclusion": "(A3 -> A4)",
          "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is granted."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A3 -> A4)",
              "prover9_expression": "(clinical_trial_completed(Drug_Candidate_A) -> regulatory_approval_granted(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is granted."
            },
            {
              "id": "Rule18",
              "prover9": "(A3 -> -A4)",
              "prover9_expression": "(clinical_trial_completed(Drug_Candidate_A) -> -regulatory_approval_granted(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are completed, then regulatory approval for Drug Candidate A is not granted."
            }
          ],
          "conclusion": "-A3",
          "natural": "Clinical trials for Drug Candidate A are not completed."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule6",
              "prover9": "(A2 -> A3)",
              "prover9_expression": "(clinical_trial_initiated(Drug_Candidate_A) -> clinical_trial_completed(Drug_Candidate_A))",
              "natural": "If clinical trials for Drug Candidate A are initiated, then clinical trials for Drug Candidate A are completed."
            },
            {
              "id": "Derived",
              "prover9": "-A3",
              "prover9_expression": "-clinical_trial_completed(Drug_Candidate_A)",
              "natural": "Clinical trials for Drug Candidate A are not completed."
            }
          ],
          "conclusion": "-A2",
          "natural": "Clinical trials for Drug Candidate A are not initiated."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule7",
              "prover9": "(A2 | (-G -> A1))",
              "prover9_expression": "(clinical_trial_initiated(Drug_Candidate_A) | (-grant_awarded(Substance_Z) -> research_funded(Project_X)))",
              "natural": "Either clinical trials for Drug Candidate A are initiated or, if a grant for Substance Z is not awarded, then Project X receives research funding."
            },
            {
              "id": "Derived",
              "prover9": "-A2",
              "prover9_expression": "-clinical_trial_initiated(Drug_Candidate_A)",
              "natural": "Clinical trials for Drug Candidate A are not initiated."
            }
          ],
          "conclusion": "(-G -> A1)",
          "natural": "If a grant for Substance Z is not awarded, then Project X receives research funding."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(-G -> A1)",
              "prover9_expression": "(-grant_awarded(Substance_Z) -> research_funded(Project_X))",
              "natural": "If a grant for Substance Z is not awarded, then Project X receives research funding."
            },
            {
              "id": "Fact2",
              "prover9": "-A1",
              "prover9_expression": "-research_funded(Project_X)",
              "natural": "Project X does not receive research funding."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule8",
              "prover9": "(A22 -> A21)",
              "prover9_expression": "(sales_decline(Drug_Candidate_A) -> price_reduction(Drug_Candidate_A))",
              "natural": "If sales of Drug Candidate A decline, then the price of Drug Candidate A is reduced."
            },
            {
              "id": "Rule10",
              "prover9": "(A23 -> (A20 -> -A18))",
              "prover9_expression": "(market_share_loss(Drug_Candidate_A) -> (generic_version_available(Drug_Candidate_A) -> -market_release(Drug_Candidate_A)))",
              "natural": "If Drug Candidate A loses market share, then, should a generic version of Drug Candidate A become available, Drug Candidate A is not released to the market."
            },
            {
              "id": "Rule9",
              "prover9": "(A22 | A23)",
              "prover9_expression": "(sales_decline(Drug_Candidate_A) | market_share_loss(Drug_Candidate_A))",
              "natural": "Either sales of Drug Candidate A decline or Drug Candidate A loses market share."
            }
          ],
          "conclusion": "(A21 | (A20 -> -A18))",
          "natural": "Either the price of Drug Candidate A is reduced or, if a generic version of Drug Candidate A becomes available, then Drug Candidate A is not released to the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A21 | (A20 -> -A18))",
              "prover9_expression": "(price_reduction(Drug_Candidate_A) | (generic_version_available(Drug_Candidate_A) -> -market_release(Drug_Candidate_A)))",
              "natural": "Either the price of Drug Candidate A is reduced or, if a generic version of Drug Candidate A becomes available, then Drug Candidate A is not released to the market."
            },
            {
              "id": "Fact5",
              "prover9": "-A21",
              "prover9_expression": "-price_reduction(Drug_Candidate_A)",
              "natural": "The price of Drug Candidate A is not reduced."
            }
          ],
          "conclusion": "(A20 -> -A18)",
          "natural": "If a generic version of Drug Candidate A becomes available, then Drug Candidate A is not released to the market."
        },
        {
          "step_number": 3,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Rule5",
              "prover9": "(A19 | A20)",
              "prover9_expression": "(competitor_launch(Drug_X) | generic_version_available(Drug_Candidate_A))",
              "natural": "Either Competitor Drug X is launched or a generic version of Drug Candidate A becomes available."
            },
            {
              "id": "Rule4",
              "prover9": "(A19 -> -A18)",
              "prover9_expression": "(competitor_launch(Drug_X) -> -market_release(Drug_Candidate_A))",
              "natural": "If Competitor Drug X is launched, then Drug Candidate A is not released to the market."
            },
            {
              "id": "Derived",
              "prover9": "(A20 -> -A18)",
              "prover9_expression": "(generic_version_available(Drug_Candidate_A) -> -market_release(Drug_Candidate_A))",
              "natural": "If a generic version of Drug Candidate A becomes available, then Drug Candidate A is not released to the market."
            }
          ],
          "conclusion": "-A18",
          "natural": "Drug Candidate A is not released to the market."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule3",
              "prover9": "(A18 | -A10)",
              "prover9_expression": "(market_release(Drug_Candidate_A) | -manufacturing_process_approved(Drug_Candidate_A))",
              "natural": "Either Drug Candidate A is released to the market or the manufacturing process for Drug Candidate A is not approved."
            },
            {
              "id": "Derived",
              "prover9": "-A18",
              "prover9_expression": "-market_release(Drug_Candidate_A)",
              "natural": "Drug Candidate A is not released to the market."
            }
          ],
          "conclusion": "-A10",
          "natural": "The manufacturing process for Drug Candidate A is not approved."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule33",
              "prover9": "(-(A8 | A9) -> A10)",
              "prover9_expression": "(-(human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B)) -> manufacturing_process_approved(Drug_Candidate_A))",
              "natural": "If neither human trials for Drug Candidate B are initiated nor an alternative formulation for Drug Candidate B is developed, then the manufacturing process for Drug Candidate A is approved."
            },
            {
              "id": "Derived",
              "prover9": "-A10",
              "prover9_expression": "-manufacturing_process_approved(Drug_Candidate_A)",
              "natural": "The manufacturing process for Drug Candidate A is not approved."
            }
          ],
          "conclusion": "(A8 | A9)",
          "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B))",
              "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
            },
            {
              "id": "Rule27",
              "prover9": "(A8 -> -A7)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If human trials for Drug Candidate B are initiated, then animal testing for Drug Candidate B is not completed."
            },
            {
              "id": "Rule28",
              "prover9": "(A9 -> -A7)",
              "prover9_expression": "(alternative_formulation_developed(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If an alternative formulation for Drug Candidate B is developed, then animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A7",
          "natural": "Animal testing for Drug Candidate B is not completed."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule25",
              "prover9": "(A6 -> A7)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) -> animal_testing_completed(Drug_Candidate_B))",
              "natural": "If the preclinical stage for Drug Candidate B is initiated, then animal testing for Drug Candidate B is completed."
            },
            {
              "id": "Derived",
              "prover9": "-A7",
              "prover9_expression": "-animal_testing_completed(Drug_Candidate_B)",
              "natural": "Animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A6",
          "natural": "The preclinical stage for Drug Candidate B is not initiated."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A6 | G)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) | grant_awarded(Substance_Z))",
              "natural": "Either the preclinical stage for Drug Candidate B is initiated or a grant for Substance Z is awarded."
            },
            {
              "id": "Derived",
              "prover9": "-A6",
              "prover9_expression": "-preclinical_stage_initiated(Drug_Candidate_B)",
              "natural": "The preclinical stage for Drug Candidate B is not initiated."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule16",
              "prover9": "(A29 | -A28)",
              "prover9_expression": "(licensing_agreement_signed(Company_B) | -partnership_formed(Company_B))",
              "natural": "Either a licensing agreement with Company B is signed or a partnership with Company B is not formed."
            },
            {
              "id": "Fact6",
              "prover9": "-A29",
              "prover9_expression": "-licensing_agreement_signed(Company_B)",
              "natural": "A licensing agreement with Company B is not signed."
            }
          ],
          "conclusion": "-A28",
          "natural": "A partnership with Company B is not formed."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule15",
              "prover9": "(A28 | (A27 -> A25))",
              "prover9_expression": "(partnership_formed(Company_B) | (existing_drug_repurposed(Drug_Candidate_A) -> new_indication_studied(Drug_Candidate_A)))",
              "natural": "Either a partnership with Company B is formed or, if Drug Candidate A is repurposed for an existing condition, then a new indication for Drug Candidate A is studied."
            },
            {
              "id": "Derived",
              "prover9": "-A28",
              "prover9_expression": "-partnership_formed(Company_B)",
              "natural": "A partnership with Company B is not formed."
            }
          ],
          "conclusion": "(A27 -> A25)",
          "natural": "If Drug Candidate A is repurposed for an existing condition, then a new indication for Drug Candidate A is studied."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            {
              "id": "Rule13",
              "prover9": "(A26 -> A24)",
              "prover9_expression": "(breakthrough_finding(Disease_Y) -> research_shifted(Disease_Y))",
              "natural": "If a breakthrough finding for Disease Y occurs, then research focus shifts to Disease Y."
            },
            {
              "id": "Derived",
              "prover9": "(A27 -> A25)",
              "prover9_expression": "(existing_drug_repurposed(Drug_Candidate_A) -> new_indication_studied(Drug_Candidate_A))",
              "natural": "If Drug Candidate A is repurposed for an existing condition, then a new indication for Drug Candidate A is studied."
            },
            {
              "id": "Rule14",
              "prover9": "(A26 | A27)",
              "prover9_expression": "(breakthrough_finding(Disease_Y) | existing_drug_repurposed(Drug_Candidate_A))",
              "natural": "Either a breakthrough finding for Disease Y occurs or Drug Candidate A is repurposed for an existing condition."
            }
          ],
          "conclusion": "(A24 | A25)",
          "natural": "Either research focus shifts to Disease Y or a new indication for Drug Candidate A is studied."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A24 | A25)",
              "prover9_expression": "(research_shifted(Disease_Y) | new_indication_studied(Drug_Candidate_A))",
              "natural": "Either research focus shifts to Disease Y or a new indication for Drug Candidate A is studied."
            },
            {
              "id": "Rule11",
              "prover9": "(A24 -> (A8 | A9))",
              "prover9_expression": "(research_shifted(Disease_Y) -> (human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B)))",
              "natural": "If research focus shifts to Disease Y, then either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
            },
            {
              "id": "Rule12",
              "prover9": "(A25 -> (A8 | A9))",
              "prover9_expression": "(new_indication_studied(Drug_Candidate_A) -> (human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B)))",
              "natural": "If a new indication for Drug Candidate A is studied, then either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
            }
          ],
          "conclusion": "(A8 | A9)",
          "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
        },
        {
          "step_number": 5,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A8 | A9)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) | alternative_formulation_developed(Drug_Candidate_B))",
              "natural": "Either human trials for Drug Candidate B are initiated or an alternative formulation for Drug Candidate B is developed."
            },
            {
              "id": "Rule27",
              "prover9": "(A8 -> -A7)",
              "prover9_expression": "(human_trials_initiated(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If human trials for Drug Candidate B are initiated, then animal testing for Drug Candidate B is not completed."
            },
            {
              "id": "Rule28",
              "prover9": "(A9 -> -A7)",
              "prover9_expression": "(alternative_formulation_developed(Drug_Candidate_B) -> -animal_testing_completed(Drug_Candidate_B))",
              "natural": "If an alternative formulation for Drug Candidate B is developed, then animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A7",
          "natural": "Animal testing for Drug Candidate B is not completed."
        },
        {
          "step_number": 6,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule25",
              "prover9": "(A6 -> A7)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) -> animal_testing_completed(Drug_Candidate_B))",
              "natural": "If the preclinical stage for Drug Candidate B is initiated, then animal testing for Drug Candidate B is completed."
            },
            {
              "id": "Derived",
              "prover9": "-A7",
              "prover9_expression": "-animal_testing_completed(Drug_Candidate_B)",
              "natural": "Animal testing for Drug Candidate B is not completed."
            }
          ],
          "conclusion": "-A6",
          "natural": "The preclinical stage for Drug Candidate B is not initiated."
        },
        {
          "step_number": 7,
          "rule_applied": "DS",
          "premises_used": [
            {
              "id": "Rule26",
              "prover9": "(A6 | G)",
              "prover9_expression": "(preclinical_stage_initiated(Drug_Candidate_B) | grant_awarded(Substance_Z))",
              "natural": "Either the preclinical stage for Drug Candidate B is initiated or a grant for Substance Z is awarded."
            },
            {
              "id": "Derived",
              "prover9": "-A6",
              "prover9_expression": "-preclinical_stage_initiated(Drug_Candidate_B)",
              "natural": "The preclinical stage for Drug Candidate B is not initiated."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            {
              "id": "Rule22",
              "prover9": "(A33 -> A34)",
              "prover9_expression": "(patent_challenged(Substance_Z) -> legal_dispute_initiated(Substance_Z))",
              "natural": "If the patent for Substance Z is challenged, then a legal dispute over Substance Z is initiated."
            },
            {
              "id": "Rule23",
              "prover9": "(A33 -> -A34)",
              "prover9_expression": "(patent_challenged(Substance_Z) -> -legal_dispute_initiated(Substance_Z))",
              "natural": "If the patent for Substance Z is challenged, then a legal dispute over Substance Z is not initiated."
            }
          ],
          "conclusion": "-A33",
          "natural": "The patent for Substance Z is not challenged."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            {
              "id": "Rule35",
              "prover9": "(-A32 -> A33)",
              "prover9_expression": "(-peer_review_completed(Substance_Z) -> patent_challenged(Substance_Z))",
              "natural": "If peer review for Substance Z is not completed, then the patent for Substance Z is challenged."
            },
            {
              "id": "Derived",
              "prover9": "-A33",
              "prover9_expression": "-patent_challenged(Substance_Z)",
              "natural": "The patent for Substance Z is not challenged."
            }
          ],
          "conclusion": "A32",
          "natural": "Peer review for Substance Z is completed."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Rule21",
              "prover9": "(A32 -> (A30 | A31))",
              "prover9_expression": "(peer_review_completed(Substance_Z) -> (research_published(Substance_Z) | conference_presentation(Substance_Z)))",
              "natural": "If peer review for Substance Z is completed, then either research on Substance Z is published or a conference presentation on Substance Z is made."
            },
            {
              "id": "Derived",
              "prover9": "A32",
              "prover9_expression": "peer_review_completed(Substance_Z)",
              "natural": "Peer review for Substance Z is completed."
            }
          ],
          "conclusion": "(A30 | A31)",
          "natural": "Either research on Substance Z is published or a conference presentation on Substance Z is made."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A30 | A31)",
              "prover9_expression": "(research_published(Substance_Z) | conference_presentation(Substance_Z))",
              "natural": "Either research on Substance Z is published or a conference presentation on Substance Z is made."
            },
            {
              "id": "Rule19",
              "prover9": "(A30 -> (A13 -> G))",
              "prover9_expression": "(research_published(Substance_Z) -> (compound_discovered(Substance_Z) -> grant_awarded(Substance_Z)))",
              "natural": "If research on Substance Z is published, then, if Substance Z is discovered, a grant for Substance Z is awarded."
            },
            {
              "id": "Rule20",
              "prover9": "(A31 -> (A13 -> G))",
              "prover9_expression": "(conference_presentation(Substance_Z) -> (compound_discovered(Substance_Z) -> grant_awarded(Substance_Z)))",
              "natural": "If a conference presentation on Substance Z is made, then, if Substance Z is discovered, a grant for Substance Z is awarded."
            }
          ],
          "conclusion": "(A13 -> G)",
          "natural": "If Substance Z is discovered, then a grant for Substance Z is awarded."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            {
              "id": "Derived",
              "prover9": "(A13 -> G)",
              "prover9_expression": "(compound_discovered(Substance_Z) -> grant_awarded(Substance_Z))",
              "natural": "If Substance Z is discovered, then a grant for Substance Z is awarded."
            },
            {
              "id": "Fact1",
              "prover9": "A13",
              "prover9_expression": "compound_discovered(Substance_Z)",
              "natural": "Substance Z is discovered."
            }
          ],
          "conclusion": "G",
          "natural": "A grant for Substance Z is awarded."
        }
      ]
    }
  ]
}